Reviewed,
UniProtKB/Swiss-Prot O00469 (PLOD2_HUMAN)
Last modified
July 7, 2009.
Version 87.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 EC=1.14.11.4 Alternative name(s): Lysyl hydroxylase 2 Short name=LH2 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 737 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links. |
| Catalytic activity | Procollagen L-lysine + 2-oxoglutarate + O2 = procollagen 5-hydroxy-L-lysine + succinate + CO2. |
| Cofactor | Iron By similarity. Ascorbate By similarity. |
| Subunit structure | Homodimer By similarity. |
| Subcellular location | Rough endoplasmic reticulum membrane; Peripheral membrane protein; Lumenal side. |
| Tissue specificity | Highly expressed in pancreas and muscle. Isoform 1 and isoform 2 are expressed in the majority of the examined cell types. Isoform 2 is specifically expressed in skin, lung, dura and aorta. Ref.2 |
| Involvement in disease | Defects in PLOD2 are the cause of Bruck syndrome 2 (BRKS2) [MIM:609220]. Bruck syndrome [MIM:259450], also known as osteogenesis imperfecta with congenital joint contractures, is an autosomal recessive disease characterized by generalized osteopenia, joint contractures at birth, fragile bones and short stature. It can be distinguished from osteogenesis imperfecta by the absence of hearing loss and dentinogenesis imperfecta, and by the presence of clubfoot and congenital joint limitations. The molecular defect is an aberrant cross-linking of bone collagen, due to underhydroxylation of lysine residues within the telopeptides of type I collagen, whereas the lysine residues in the triple helix are normal. Ref.7 Ref.8 |
| Sequence similarities | Contains 1 PKHD (prolyl/lysyl hydroxylase) domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O00469-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O00469-2) Also known as: A; The sequence of this isoform differs from the canonical sequence as follows: 500-500: M → MTLQREKDSPTPETFQMLSPPK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | ||||||
| Chain | 26 – 737 | 712 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | PRO_0000024683 | |||||
Regions | |||||||||
| Domain | 563 – 737 | 175 | PKHD | ||||||
Sites | |||||||||
| Active site | 728 | 1 | Potential | ||||||
| Metal binding | 666 | 1 | Iron By similarity | ||||||
| Metal binding | 668 | 1 | Iron By similarity | ||||||
| Metal binding | 718 | 1 | Iron By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 320 | 1 | Phosphothreonine Ref.4 | ||||||
| Modified residue | 323 | 1 | Phosphotyrosine Ref.4 | ||||||
| Glycosylation | 63 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 209 | 1 | N-linked (GlcNAc...) | ||||||
| Glycosylation | 297 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 365 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 522 | 1 | N-linked (GlcNAc...) | ||||||
| Glycosylation | 696 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 725 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 500 | 1 | M → MTLQREKDSPTPETFQMLSP PK in isoform 2. | VSP_013467 | |||||
| Natural variant | 598 | 1 | R → H in BRKS2. Ref.8 | VAR_022164 | |||||
| Natural variant | 601 | 1 | G → V in BRKS2. Ref.7 | VAR_022165 | |||||
| Natural variant | 608 | 1 | T → I in BRKS2. Ref.7 | VAR_022166 | |||||
Experimental info | |||||||||
| Sequence conflict | 624 | 1 | H → D in AAB58363. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and characterization of a novel human lysyl hydroxylase isoform highly expressed in pancreas and muscle." Valtavaara M., Papponen H., Pirttila A.M., Hiltunen K., Helander H., Myllylae R. J. Biol. Chem. 272:6831-6834(1997) [PubMed: 9054364] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Kidney. |
| [2] | "Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene." Yeowell H.N., Walker L.C. Matrix Biol. 18:179-187(1999) [PubMed: 10372558] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY. Tissue: Skin fibroblast. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Placenta. |
| [4] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-320 AND TYR-323, MASS SPECTROMETRY. Tissue: Platelet. |
| [5] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [6] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-209 AND ASN-522, MASS SPECTROMETRY. Tissue: Liver. |
| [7] | "Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis." van der Slot A.J., Zuurmond A.-M., Bardoel A.F.J., Wijmenga C., Pruijs H.E.H., Sillence D.O., Brinckmann J., Abraham D.J., Black C.M., Verzijl N., DeGroot J., Hanemaaijer R., TeKoppele J.M., Huizinga T.W.J., Bank R.A. J. Biol. Chem. 278:40967-40972(2003) [PubMed: 12881513] [Abstract] Cited for: VARIANTS BRKS2 VAL-601 AND ILE-608. |
| [8] | "Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2." Ha-Vinh R., Alanay Y., Bank R.A., Campos-Xavier A.B., Zankl A., Superti-Furga A., Bonafe L. Am. J. Med. Genet. A 131:115-120(2004) [PubMed: 15523624] [Abstract] Cited for: VARIANT BRKS2 HIS-598. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| U84573 mRNA. Translation: AAB58363.1. BC037169 mRNA. Translation: AAH37169.1. | |
| IPI | IPI00337495. IPI00472165. |
| PIR | A59144. |
| RefSeq | NP_000926.2. NP_891988.1. |
| UniGene | Hs.477866 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O00469. 1 interaction. |
PTM databases | |
| PhosphoSite | O00469. |
Proteomic databases | |
| PRIDE | O00469. |
Genome annotation databases | |
| Ensembl | ENSG00000152952. Homo sapiens. [Contig view] |
| GeneID | 5352. |
| KEGG | hsa:5352. |
| UCSC | uc003evr.1. human. uc003evs.1. human. |
Organism-specific databases | |
| GeneCards | GC03M147269. |
| HGNC | HGNC:9082. PLOD2. |
| MIM | 601865. gene. 609220. phenotype. |
| Orphanet | 2771. Bruck syndrome. |
| PharmGKB | PA33412. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | O00469. |
| OMA | O00469. LNNVGED. |
Enzyme and pathway databases | |
| BRENDA | 1.14.11.4. 247. |
Gene expression databases | |
| ArrayExpress | O00469. |
| Bgee | O00469. |
| CleanEx | HS_PLOD2. |
| GermOnline | ENSG00000152952. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR005123. Oxoglutarate/Fe-dep_Oase. IPR006620. Pro_4_hyd_alph. IPR001006. Procol_lys_dOase. [Graphical view] |
| Pfam | PF03171. 2OG-FeII_Oxy. 1 hit. [Graphical view] |
| ProDom | PD011578. ProcolLys_dioxy. 1 hit. [Graphical view] [Entries sharing at least one domain] |
| SMART | SM00702. P4Hc. 1 hit. [Graphical view] |
| PROSITE | PS01325. LYS_HYDROXYLASE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| DrugBank | DB00126. Vitamin C. |
| NextBio | 20746. |
| SOURCE | Search... |
Entry information
| Entry name | PLOD2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O00469 Secondary accession number(s): Q8N170 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


